HORIBA Medical showcased the very latest additions to its Yumizen G range of haemostasis analysers and reagents at the ISTH 2022 Congress recently.
HORIBA Medical introduced its new-generation Yumizen G800 and G1550 haemostasis analysers, as well as new ready-to-use reagents for frequently undertaken blood coagulation tests. With these introductions, HORIBA Medical now offers a complete portfolio of haemostasis systems and an innovative reagent range suitable for all laboratory sizes and requirements.
Alongside its specialist Yumizen G haemostasis range, the company also demonstrated its HELO laboratory automation platforms for haematology. Based on the combination of innovative and proven technologies, the HELO solution is capable of enhancing productivity and efficiency of any type of laboratory.
HORIBA Medical’s comprehensive Yumizen G haemostasis product range fully supports high-quality and cost-effective screening and assessment of bleeding disorders. At ISTH 2022, the company presented a variety of new specialty reagent additions to this range, including dRVVT, protein S, protein C and antithrombin screening and confirmation.
The new generation of HORIBA Medical Yumizen G800 and G1550 automated analysers are designed for managing the coagulation, thrombophilia diagnostics and monitoring requirements of clinical laboratories with mid- to high workloads. Supporting coagulant nephelometry, immunoturbidimetric and chromogenic testing, these analysers offer independent and integrated measurement channels.
The new haemostasis line also includes: liquid reagents for more than 80% of laboratory activity; pre-calibrated tests; continuous sample access and loading; as well as innovative management of reflex and additional tests. For urgent samples, it also offers eight STAT sample positions available at any time. Yumizen G systems use only one cuvette per test to avoid waste and overconsumption. The Yumizen G range has been designed to optimise costs, reduce expenses and reduce impact on the environment.
At ISTH 2022, HORIBA hosted a symposium with key opinion-leaders in haemostasis from the UK and France presenting on the latest reagent evaluations and advancements in thrombophilia diagnosis. These academic experts included Dr Annette Bowyer, Sheffield Haemophilia and Thrombosis Centre, discussing APTT reagents; Dr Laurie Talon, University Hospital of Clermont-Ferrand, evaluating a new D-dimer assay; and Dr Pierre Suchon, Aix-Marseille University, considering the diagnosis of protein S deficiencies. Details of their presentations are available online below.
